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ABSTRACT
Angiogenesis and inflammation are two intermingled processes that play a role in wound healing. Nevertheless, whenever exacerbated, these
processes result in nonhealing wounds. Xanthohumol (XN), a beer-derived polyphenol, inhibits these processes in many physiopathological
situations. This study aimed at examining whether XN ingestion affects wound healing. Wistar rats drinking water, 5% ethanol, stout beer (SB)
or stout beer supplemented with 10 mg/L XN (Suppl SB) for 4 weeks, were subjected to a 1.5 cm full skin-thickness longitudinal incision, and
further maintained under the same beverage conditions for another week. No differences in beverage consumption or body weight were found
throughout the study but food intake decreased in every group relative to controls. Consumption of Suppl SB resulted in decreased serum
VEGF levels (18.42%), N-acetylglucosaminidase activity (27.77%), IL1b concentration (9.07%), and NO released (77.06%), accompanied by a
reduced redox state as observed by increased GSH/GSSG ratio (to 198.80%). Also, the number of blood vessels within the wound granulation
tissue seems to reduce in animals drinking Suppl SB (23.08%). Interestingly, SB and primarily Suppl SB showed a tendency to increase
adipocyte number (to 194.26% and 156.68%, respectively) and reduce adipocyte size (4.60% and 24.64%, respectively) within the granuloma.
Liver function and metabolism did not change among the animal groups as analyzed by plasma biochemical parameters, indicating no
beverage toxicity. This study shows that XN intake in its natural beer context reduced inflammation, oxidative stress, and angiogenesis,
ameliorating the wound healing process, suggesting that this polyphenol may exert beneficial effect as a nutritional supplement.
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A ngiogenesis, the formation of new capillaries from pre-existent blood vessels, is a complex and highly regulated
process that requires interaction between different types of cells,
inflammatory cytokines, growth factors, and the extracellular
matrix. Angiogenesis is a major contributor to tissue vascularization
with primordial importance both in physiology and disease, as blood
vessels are responsible for the transport of oxygen, nutrients, and
other molecules to tissues and for removing metabolic waste [Costa
et al., 2007].
Under physiological conditions, angiogenesis is highly regulated
by the balance between pro- and anti-angiogenic factors, and in
adulthood it occurs only in self-limited processes as for example in
wound repair and tissue regeneration [Gollisch et al., 2009].
Pathological angiogenesis, inversely, may develop during years
[Folkman, 2007] in conditions such as in cancer, cardiovascular
disease, diabetes, obesity, and other pathologies associated with
chronic inflammation.
In mammals, wound healing is a result of three overlapping
processes: Hemostasis and inflammation, granulation tissue
formation, re-epithelialization and remodelling, which enable
wound closure and the restoration of a functional barrier
[Tan et al., 2007]. Wound healing normally develops without
complications, but the resolution of inflammation is critical. Indeed,
several conditions like ageing, obesity, and many other disorders
can compromise the normal resolution of the inflammation. This can
result in chronic wound and ulcer development, leading to tissue
damage [Pond, 2003]. Hence, reduction of the inflammatory phase is
the aim of several therapeutic measures in order to resolve chronic
wounds.
Macrophages are the most abundant cells 5 days upon wound
injury, producing cytokines and growth factors required for wound
healing, promoting collagen production, angiogenesis, and re-
epithelization with the formation of granulation tissue, the hallmark
of an establishing healing response [Mahdavian Delavary et al.,
2011]. Wound angiogenesis starts right at the beginning of the
healing process and is amplified by inflammation and hypoxia, two
driving forces for wound angiogenesis, leading to the production of
VEGF, the most potent pro-angiogenic factor. VEGF, in turn,
promotes blood vessel permeability enabling inflammatory factors
and nutrients release necessary for the healing process, and also the
survival and proliferation of endothelial cells (EC), guiding the
newly formed blood vessels, that appear in the wound bed by
3–5 days after injury. EC, vascular smooth muscle cells (VSMC),
macrophages, fibroblast, and extracellular matrix present in the
wound area secrete several angiogenic factors, growth factors, and
proteases that support the angiogenic process. At later stages of the
healing process these regulators gradually return to normal level,
which enhance new blood vessels stability [Chung et al., 2010].
When insufficient angiogenic stimulation occurs, it compromises
the neovascularization and the normal regeneration of the wounded
tissue, as new blood vessels are fundamental for the formation of the
provisional matrix and for the delivering of oxygen and nutrients to
growing tissue and removing metabolic waste products [Eming
et al., 2007]. However, excessive pro-angiogenic stimulation also
may result in poor perfusion as abnormal and no functional
capillaries are formed. Both processes can result in chronic wound
and ulcer development [Shoab et al., 1999].
Epidemiological and experimental evidence indicates that diets
rich in plant-derived food protect from several pathologies,
associated with inflammatory and angiogenic processes [Gerhauser,
2005; Oak et al., 2005; Soares and Azevedo, 2007]. These properties
have mainly been attributed to the anti-oxidant and anti-
inflammatory effects of polyphenolic compounds [Biesalski,
2007; Stevenson and Hurst, 2007].
Beer consumption has increased worldwide, especially among the
young generations. Beer contains more than 800 compounds, many
of which are polyphenols that contribute to its flavour character-
istics. Many of these polyphenols have been described as potent
anti-oxidative, anti-inflammatory and anti-carcinogenic molecules,
being, thus, possible contributors to the prevention of pathologies
with high incidence and mortality rates in the western world
[Stevens and Page, 2004; Gerhauser, 2005; Cho et al., 2008;
Magalhaes et al., 2009].
Xanthohumol (XN) is a polyphenol almost exclusively present in
hops, used in beer production. Due to the described health properties
attributed to XN, as anti-cancer, anti-invasive, anti-angiogenic,
anti-inflammatory, and anti-oxidant [Gerhauser, 2005; Albini et al.,
2006; Guerreiro et al., 2007; Monteiro et al., 2008; Negrao et al.,
2010], production of a polyphenol-enriched beer has been
considered an interesting challenge to the brewing industry,
particularly, because most beer production processing results in
beers with a very low content in XN (0.002–1.2mg/L) [Gerhauser,
2005].
In 2004, two new beverages were introduced in the German
market, XAN Hefeweissbeer1 and XAN Wellness1, with elevated
levels of XN (1.4mg/L and 4mg/L respectively) [Winkelmann,
2004; Magalhaes et al., 2009]. Other following XN-enriched
products are in development and trial, namely muesli bars,
chocolate, yoghurt, bread, pastries, and biscuits (Xan products,
TA-XAN AG, Company SCHULTZEPLUS, Germany) [Xan, 2011].
Nevertheless, the use of these food additives must be carefully taken,
as very few studies about the safety of these additives were
performed until now.
Previous work of our group demonstrated that different
polyphenols present in beer exert different effects on angiogenesis
and inflammation, resulting in differences in the wound healing
process when these compounds were administered topically in the
wound area [Negrao et al., 2010]. Namely, whereas 8-prenylnar-
ingenin (8PN) stimulates angiogenesis, XN and isoxanthohumol
(IXN) manifested anti-angiogenic and anti-inflammatory effects in
identical conditions [Negrao et al., 2010].
In beer, these polyphenols are not isolated, being mixed with
several other compounds in a complex matrix that may alter their
final biological effect. Moreover, the administration route (e.g.,
ingestion vs. topical application) of polyphenols might lead to
different actions in the body. The effects of the ingestion of XN were
already studied by several groups [Albini et al., 2006; Monteiro
et al., 2008; Bolca et al., 2010; Dorn et al., 2010]. However, the
effects of beer and XN-supplemented beer ingestion on inflamma-
tion and angiogenesis were not clearly examined.
Given its dependence on angiogenesis and inflammation,
wound healing is a good model for studying the effects of
polyphenols in these two processes. In this work, we aimed to
determine whether prolonged stout beer (SB) and XN supplemented
stout beer (10mg/L) intake could influence skin wound healing
process, through angiogenesis and inflammation modulation.
Furthermore, since adipose tissue is known to play a major role
in oxidative stress and in the inflammatory process, we did also
characterize the presence and morphology of adipocytes within skin
damage tissue.
MATERIALS AND METHODS
IN VIVO STUDIES
All research animals were obtained, maintained, and used in
experiments conducted according to accepted standards of humane
animal care (Declaration of Helsinki, European Community guide-
lines (86/609/EEC) and Portuguese Act (129/92) for the use of
experimental animals). A veterinary accompanied all steps involv-
ing animal care and manipulation. All the authors involved in
animal studies in the present study received accreditation from the
Portuguese Veterinarian Administration as a competent person for
animal experimentation (investigator–coordinator).
BEER INFORMATION
The beer used in this study was Superbock1 SB (UNICER, Porto,
Portugal), with the forward polyphenols composition: Polyphenols:
255 13mg/L; XN: Traces (mM). The final concentration in the
supplemented stout beer was 10mg/L. In order to ensure batch-to-
batch consistency in XN levels in the baseline beer, we used SB from
the same batch along all the experiment, assuring consistency
regarding this point along the experiment.
SKIN WOUND-HEALING ASSAY
Wistar rats (Charles River, Wilmington, MA,), 6-week-old, were
maintained under standard temperature and light conditions (20–
228C, 12-h light/dark cycle). The animals were divided into four
groups, of six animals each, that were subjected to different
treatments: (1) water (control group, C), (2) 5% ethanol solution in
water (Et), (3) Superbock1 SB, and (4) Superbock1 SB supplemented
with XN 10mg/L (Suppl SB). The beverages were supplied to the rats
ad libitum in dark bottles. All animals were maintained on standard
ad libitum rodent chow. Body weight gain was monitored twice
weekly. Beverages and animal pellet food were renewed and intake
was assessed every 2–3 days. After 4 weeks of treatment, the animals
were anesthetized, dorsal skin of the rat was shaved and cleaned.
Full skin-thickness longitudinal incisions (1.5 cm) were created on
the dorsal surface of the rat and the wound edges closed with
surgical sutures at 0.5 cm intervals. The animals were kept in
individual cages and continued beverage treatment for another
week. Rats were examined daily for wound healing progression.
After 7 days the animals were anesthetized and blood was drawn
from the left ventricle to heparin-containing tubes for glutathione
determination in plasma. Serum was also obtained for inflammatory
factors and biochemical parameters evaluation. Wound tissue was
removed, fixed in 10% neutral-buffered formalin, paraffin-embed-
ded, and sectioned for histological and immunohistochemical
analyses.
EVALUATION OF PLASMA BIOCHEMICAL PARAMETERS
Plasma biochemical markers were measured in the Central
Laboratory, Department of Clinical Pathology, Hospital Sa˜o Joa˜o,
using conventional methods with an Olympus AU54001 automated
clinical chemistry analyzer. (Beckman-Coulter1, Izasa, Porto,
Portugal). Parameters evaluated included hepatic function markers
such as aspartate aminotransferase (AST), alanine aminotransferase
(ALT), and alkaline phosphatase (ALP) and markers of metabolic
status including glucose, uric acid, triglycerides, total cholesterol,
very low density lipoproteins cholesterol (VLDL), low density
lipoproteins cholesterol (LDL), and high density lipoproteins
cholesterol (HDL). LDL was calculated according to Friedewald’s
equation [Friedewald et al., 1972]: LDL-cholesterol¼ total
cholesterolHDL-cholesterol(triglycerides/5). VLDL¼ TRG/5.
GSH AND GSSG DETERMINATION IN RAT PLASMA
Chromatographic detection of GSH/GSSG was performed as
described in Glutathione (GSH/GSSG) HPLC Kit (Immundiagnostik,
Germany) using a reverse-phase HPLC VWR-Hitachi Elite LaChrom
System (VWR, Germany) and plasma samples. The system consisted
of a pumpmodel L-2130, an autosampler L-27200, a L-2300 Column
Oven, a BDS-Hypersil C18 analytical column (10 cm 4.6mm i.d.;
3-mmparticle size) (Thermo Scientific) with no guard column and an
FL detector model L-2485. After running the samples, the
chromatograms were analyzed using Agilent EZChrom Elite 3.3.2
software (Agilent Technologies).
IMMUNOHISTOCHEMISTRY ANALYSIS
The microvessel density was evaluated in each formalin-fixed
paraffin-embedded wounded tissue section. Immunostaining for
von-Willebrand Factor (vWF) diluted 1:100 (Millipore, MA) was
preceded by tissue slide digestion with pepsin freshly prepared
solution (0.5% in 5mM HCl) at 378C for 20min. Negative controls
were carried out by omission of the primary antibody in tissue
sections expressing the marker. To ensure specific immunostaining
by vWF, tissue slides of paraffin-embedded B16 mellanoma tumors
were immunostained against vWF. Microvessel density was then
evaluated in three tissue sections, for each animal, and normalised to
the total area of the tissue section.
ELISA ASSAYS
VEGF was quantified in rats serum by ELISA (Rat VEGF
immunoassay kit, R&D Systems, Abingdon, UK) according to the
manufacturer’s instructions.
Interleukin (IL) 1b was quantified in rats serum by ELISA (IL-1b-
EASIA kit, BioSource, Nivelles, Belgium) according to the
manufacturer’s instructions.
DETERMINATION OF N-ACETYLGLUCOSAMINIDASE ACTIVITY
TheN-acetylglucosaminidase (NAG) enzyme is present at high levels
in activated macrophages. Inflammation can be evaluated by
measuring the levels of the lysosomal NAG enzyme in the serum.
Serum was incubated for 10min at 378C with 100ml of p-
nitrophenyl-N-acetyl-beta-D-glucosaminide solution in a 96-well
plate. The reaction was stopped by the addition of 0.2M glycine
buffer (pH 10.6) and the subtrate hydrolysis was measured at
405 nm.
NO DETERMINATION
NO level was determined as the concentration of nitrate plus nitrite
in the serum by colorimetric assay. Serum was incubated with equal
volume of Griess Reagent in a 96-well microtiter plate, for 15min at
room temperature. Measurement was performed in a spectropho-
tometer plate reader at 550 nm. Data were expressed as NO
concentration (mM).
ADIPOCYTE SIZE AND NUMBER
Hematoxylin- and eosin-stained 5mm-thick paraffin-embedded
sections of wound healing areas were observed in a blind study and
adipocyte size measurement and quantification were performed as
described. Briefly, microscopic pictures covering the whole analyzed
area were taken. Using Adobe Photoshop CS5, a compound image
was created with all the acquired pictures. All adipocytes were then
outlined and adipocyte number and area measurements were
computed automatically.
STATISTICAL ANALYSES
Every assay was performed at least in three independent
experiments. Quantifications are expressed as mean SEM and/or
as percentage of control, which was considered to be 100%.
Statistical significance of difference between various groups was
evaluated by analysis of variance (ANOVA) followed by the
Bonferroni test. A difference between experimental groups was
considered significant with a confidence interval of 95%, whenever
P 0.05.
RESULTS
FOOD AND BEVERAGE INTAKE AND BODY WEIGHT MEASUREMENT
Every group ingested the same amount of beverage per day.
However, the higher caloric intake among the groups drinking 5%
ethanol-containing beverages was compensated by the ingestion of
significantly smaller amounts of food by Et (7.23 0.23 g/day/100 g
body weight), SB (6.65 0.25 g/day/100 g body weight), and Suppl
SB (6.35 0.24 g/day/100 g body weight) treated animals when
compared to control group (8.30 0.24 g/day/100 g body weight)
(Fig. 1A,B).
We next examined whether the different treatments exerted any
influence on rat body weight. Body weight gradually increased in
every studied group throughout the 5 weeks of treatment, exhibiting
an identical rate of weight gain for each group (Fig. 1C).
Accordingly, at the end of experiment (5 weeks), body weight did
not differ between the four groups of treated animals (Fig. 1C).
BIOCHEMICAL PARAMETERS AND HEPATIC ENZYME
ACTIVITY EVALUATION
We then analyzed hepatic and biochemical serum parameters as
indicators of liver damage and function, and of metabolism, after
different beverage treatments. The hepatic enzyme activities of ALT,
AST, gamma-glutamyltransferase (GGT), and ALP exhibited similar
values among the four different treated animal groups, indicating
that there was no hepatic toxicity with the ingested doses of these
beverages, during 5 weeks (Table I).
In order to evaluate the metabolic profile of the studied animals,
we also quantified biochemical parameters including glucose, uric
acid, triglycerides, cholesterol, VLDL, LDL, and HDL. Careful
analysis of Table I seemed to indicate a similar decrease in plasma
triglycerides in both SB and Suppl SB, two tested beers with very
different quantities of bioactive components, comparatively to C
and Et groups. However, statistical analysis of the results did not
confirm that difference. No significant alterations were observed for
all other biochemical parameters, confirming a normal hepatic cell
function regarding carbohydrate and lipid metabolism (Table I).
Fig. 1. Mean values for (A) beverage and (B) food intake byWistar rats subjected to distinct treatments during 5 weeks. C: Rat body weight measurement during the five-week
treatment with the different beverages intake. C, control group; Et, 5% ethanol solution in water; SB, Superbock
1
stout beer; Suppl SB, xanthohumol-supplemented
Superbock1 stout beer. Results are presented as means SEM (n¼ 7) P 0.05 versus C.
SB AND SUPPL SB BEVERAGE TREATMENTS IMPROVED
ANTI-OXIDANT DEFENSES
To characterize the general redox state after 5 weeks of treatment
with the study beverages, we evaluated endogenous anti-oxidant
defenses. As reduced glutathione (GSH) plays a critical role in the
maintenance of the thiol redox status in cells, the determination of
GSH or the GSH/oxidized glutathione (GSSG) ratio is a useful marker
of oxidative stress. The effect of treatments on plasma glutathione
levels is illustrated in Figure 2. Chronic consumption of both SB and
Suppl SB resulted in an increase of plasma GSH levels (to
124.79 7.60% and 152.69 11.41%, respectively) as compared
to C (100.00 15.04%) and Et (97.21 18.37%) groups. Neverthe-
less, a statistically significant difference was only observed in the
group that ingested Suppl SB. No differences were found between C
and Et groups. In contrast, all the beverages significantly reduced
serum GSSG levels to 68.33 11.12% (Et), 51.84 3.88% (SB), and
56.47 4.85% (Suppl SB) relatively to control group. Accordingly,
the GSH/GSSG ratio in rat plasma increased slightly in Et treated
animals (to 134.31 16.65%), and significantly in SB (to
163.82 10.02%) and Suppl SB (to 198.80 8.44%) groups. This
latter showed a significant increase in comparison both to C and Et
rat groups (Fig. 2). Altogether, these findings indicate that XN-
enriched beer is able to increase systemic anti-oxidant defences in
skin-injured Wistar rats.
POLYPHENOL-RICH BEVERAGES DIMINISHED LOCAL AND
SYSTEMIC ANGIOGENESIS AND INFLAMMATORY MARKERS
Skin wound healing is a process involving the formation of new
extracellular matrix, cell infiltration, and tissue remodeling. Two
fundamental physiological phenomena are deeply implicated in this
process: Inflammation and angiogenesis. On day 7 post-injury,
macroscopic evaluation of the external surface of the healing area,
in the dorsal skin of the animals, showed no differences in the wound
area after a 7-day treatment with any beverage, comparatively to the
control group. However, the corresponding histological sections
revealed that the granulation tissue of the incision area of animals
treated with Suppl SB seemed more homogeneous, thinner, and with
less inflammatory infiltration than that of control animals
(Fig. 3C,D).
The ingestion of 5% ethanol was accompanied by a slight increase
in the number of blood vessels in the wounded area (21.10
2.19 vessels/mm2) in comparison to controls (16.68 1.51 vessels/
mm2). Inversely, SB (15.88 1.94 vessels/mm2) and Suppl SB
(12.83 1.00 vessels/mm2) ingestion led to a tendency to micro-
vessel density reduction (Fig. 3A,B) surrounding the wounded area,
although none of these observed effects reached statistical
significance relative to controls. Interestingly, consumption of
XN-enriched beer resulted in a significant decrease in the number of
blood vessels within the wounds when compared to ethanol treated
mice (#P< 0.05 vs. Et).
An identical profile was found for serum VEGF quantification
(Fig. 4A). Ingestion of 5% ethanol increased VEGF in the serum
(60.74 2.94 pg/ml) comparatively to control group (52.43
0.80 pg/ml) (P 0.05 vs. C). In contrast, consumption of SB and
Suppl SB significantly reduced VEGF levels in rats serum
(47.51 1.71 pg/ml and 42.77 0.30 pg/ml, respectively). Remark-
ably, VEGF was significantly decreased in Suppl SB as compared to
C, Et, and SB.
The activity of pro-inflammatory markers in rats serum followed
the same outline. NAG activity was higher in Et group
(150.18 8.32%), revealing an increased systemic inflammatory
TABLE I. Analysis of Plasma Biochemical Markers in Wistar Rats After 5-Week Consumption of Water (C, Control), 5% Ethanol (Et), Stout
Beer (SB), or XN-Supplemented Stout Beer (Suppl SB)
C Et SB Suppl SB
AST (U/L) 103.4 13.04 80.3 8.78 69.0 4.28 75.0 7.0
ALT (U/L) 26.0 0.7 26.0 1.79 23.8 1.9 21.67 2.36
AST/ALT 3.8 0.7 3.2 0.3 3.1 0.4 3.1 0.2
ALP (U/L) 116.7 9.7 91.3 7.1 144.8 13.7 108.2 14.0
GGT(U/L) 2.0 0.2 1.3 0.3 2.0 0.2 2.8 0.2
Glucose (mg/dl) 147.0 7.0 189.0 36.0 135.0 6.0 160.0 9.0
Uric acid (mg/dl) 1.09 0.06 0.91 0.12 0.73 0.07 0.74 0.14
Triglycerides (mg/dL) 90.0 7.0 87.0 8.0 64.0 8.0 68.0 9.0
Cholesterol (mg/dl) 43.0 2.0 41.0 2.0 41.0 2.0 47.0 3.0
VLDL (mg/dl) 23.0 3.0 22.0 3.0 18.0 4.0 18.0 4.0
LDL (mg/dl) 12.0 1.0 11.0 1.0 11.0 1.0 12.0 1.0
HDL (mg/dl) 23.0 1.0 26.0 2.0 23.0 1.026.0 25.0 2.0
Evaluated parameters included hepatic function markers, such as aspartate aminotransferase (AST), alanine aminotransferase (ALT), gamma-glutamyltransferase (GGT),
and alkaline phosphatase (ALP) activities and markers of metabolic status including glucose, uric acid, triglycerides, total cholesterol, very low density lipoprotein
cholesterol (VLDL), low density lipoprotein cholesterol (LDL), and high density lipoprotein cholesterol (HDL). Results are presented as means SEM of independent
experiments (4 n 6).
Fig. 2. Chromatographic detection of GSH and GSSG in plasma of animals
treated with C, water control group; Et, 5% ethanol solution in water; SB,
Superbock1 stout beer; Suppl SB, xanthohumol-supplemented Superbock1
stout beer. Results are means SEM (4 n 6) and are expressed as percent-
age of control. P 0.05 versus C; #P 0.05 versus Et.
status significantly different from control group (100.00 16.94%)
and diminished to values similar to those obtained with control
groups in rats that ingested SB (106.04 10.04%), decreasing even
more for Suppl SB (to 72.23 8.62%) (Fig. 4B). These latter
findings were corroborated by an identical profile obtained for
IL1b determination (Fig. 4C). Et increased IL1b levels in serum
to 138.13 2.00% and Suppl SB diminished its levels to
90.93 1.53%.
NO determinations resulted in a highly significant NO reduction
for both SB and Suppl SB treatments to 35.23 1.84% and to
22.94 2.68%, respectively. Serum NO amount in Et group
(106.11 7.55%) was similar to that observed in C group
(100.00 13.12%).
SB AND SUPPL SB TEND TO INCREASE ADIPOCYTE NUMBER AND
DIMINISH ITS SIZE IN THE WOUND SITE AREA
A closer observation of the skin damaged tissue revealed that the
presence of adipocytes within granulation tissue was distinct among
the different groups (Fig. 3A). These findings, together with the
recent established role of adipocytes in inflammation, prompted us
to determine the size and number of these cells in wound healing
process after SB or Suppl SB consumption.
Determination of adipocyte area revealed a tendency to a
progressive decrease of the adipocyte size in SB (476.0 21.50mm2)
and Suppl SB (376.0 45.88mm2) when compared to C
(499.0 64.01mm2) and to Et (515.5 23.55mm2) treated animals.
This reduction in adipocyte size seemed higher for Suppl SB,
although this difference did not reach statistical significance
(Fig. 5A). Histological analysis also revealed that the number of
adipocytes in the wound-healing area tended to increase in SB
(76.25 18.12 adipocyte /mm2) and Suppl SB (61.50 11.50 adi-
adipocyte /mm2) when compared to C (39.25 6.25 adipocyte /
mm2) and Et treated (37.43 4.95 adipocyte /mm2) groups, although
again not reaching statistical significance (Fig. 5B).
DISCUSSION
Wound healing is a physiological process necessary for repair and
regeneration of injured skin tissue. This process greatly depends
on the crosstalk between inflammation, oxidative stress, and
Fig. 3. Skin wound-healing assay. After 4 weeks of beverage supplied to the rats ad libitum in dark bottles, longitudinal incisions were created on the dorsal surface of the rats
and beverages were supplied for more 7 days. Water control group (C); 5% ethanol solution in water (Et); Superbock1 stout beer (SB); and xanthohumol supplemented stout
beer (Suppl SB). Then, wound tissue was collected for angiogenesis evaluation. A, wound tissue section micrographs, using anti-von-Willebrand Factor (vWF) for evaluation of
blood vessels (immunostaining, magnification: 200). Black arrows indicate blood vessels. B, quantification of blood vessels present in three tissue sections, for each animal,
and normalized to the total area of the tissue section. Results are presented as means SEM (4 n 6), #P< 0.05 vs. Et. C: Control (C) and (D) Suppl SB, immuno-stained
micrographs of wound tissue sections, highlighting different thickness of granulation tissue fulfilling the incision with different treatments (magnification: 40).
angiogenesis [Soares, 2009]. Discovering novel promoters of
optimal wound healing, as well as identifying possible nutritional
intervention factors able to ameliorate the process becomes a
mandatory issue, as compromise of the normal resolution of the
inflammation and angiogenic processes, can result in chronic
wound and ulcer development, leading to tissue damage.
The current study demonstrates that consumption of SB and
particularly XN-supplemented stout beer (Suppl SB) seemed to
improve wound healing resolution. We were able to show that Suppl
SB wound bed seemed better re-epithelizated than the correspon-
dent area in control group. Also, the number of blood vessels tends
to decrease in rat wounds consuming Suppl SB, and this was
accompanied by reduced levels of VEGF, oxidative stress, and
inflammatorymarkers in blood serum. Altogether, these findings led
us to assume that wound healing enhancement was due to a
reduction in the inflammatory phase and consequently a more
controlled angiogenic process.
Inflammatory cells appear very rapidly in a wound after injury
and remain until 3–5 days, as reported by Kagawa and collaborators
[Kagawa et al., 2009]. Accordingly, our results demonstrate that at
day 7, SB and Suppl SB diminished the levels of inflammatory
markers, namely IL-1b, NAG activity, and NO. On contrary, at this
time point, rats treated with Et exhibited increased systemic IL-1b
and NAG activity, indicating the occurrence of macrophage
activation.
Although with different etiology, most chronic wounds result
from a deficient progression from the inflammatory to the
granulation tissue formation. Abnormal macrophage infiltration
and prolonged inflammation has been described in chronic and
diabetic wounds [Loots et al., 1998; Rodero and Khosrotehrani,
2010]. So, the decrease in systemic inflammatory markers observed
after SB and Suppl SB consumption may result in a better
controlled inflammatory response, in the presence of polyphenols,
which were even able to overcome the pro-inflammatory profile
induced by the ethanol present in the tested beverages. A better
regulation of the inflammatory phase could improve wounds
healing characterized by an excessive inflammatory profile,
through a better transition to the granulation phase. Patients
with chronic venous ulcers have sustained higher production of
VEGF in the wound, which explains the vascular permeability and
increased transudation of the wound area, resulting in disruptive
new vessels [Shoab et al., 1999]. The decreased VEGF levels,
observed for Suppl SB treatment, together with improved
inflammatory conditions, could promote the stabilization of the
new blood vessels, resulting in a better perfusion of the wounded
tissue, helping the resolution of this kind of chronic wounds.
Diabetic wounds also exhibit delayed wound closure but in contrast,
VEGF levels are lower, leading to poor angiogenesis. Qiao
demonstrated that the number of EC in diabetic rat wounds is
identical to that found in nondiabetic wounds, but they were unable
to form functional vessels [Qiao et al., 2011]. Then, chronic wounds
may differ accordingly to established pathologies. In some
situations wound resolution would improve by diminishing
angiogenic stimulation and in others by enhancing angiogenesis.
Fig. 4. Evaluation of angiogenesis and inflammatory markers in skin injured Wistar rats, after 4 weeks of beverage supplied to the rats ad libitum in dark bottles. C, Water
control group; Et, 5% ethanol solution in water; SB, Superbock1 stout beer; Suppl SB, xanthohumol-supplemented Superbock1 stout beer. Longitudinal incisions were created
on the dorsal surface of the rats and beverages were supplied for more 7 days. Blood was then collected for systemic angiogenesis and inflammation markers evaluation. A: VEGF
levels; (B) N-acetylglucosaminidase (NAG) activity; (C) IL1b levels; (D) NO levels. Results are presented as means SEM (4 n 6) and are expressed as percentage of control.
P 0.05 versus C; #P 0.05 versus Et; §P 0.05 versus SB.
But not always an increase in angiogenesis is related to better
perfusion of the wound area, as the new blood vessels need to have
conditions to stabilize and function properly. As polyphenols, and
more specifically XN, can act simultaneously in different molecular
targets, involving both inflammation and angiogenesis, the
resulting regulation of the interplay of these two processes can
improve chronic and also normal wound healing resolution, as XN
can finely modulate inflammation and angiogenesis, accordingly to
the progression of wound environment.
The study was accomplished by providing beverages to rats
during a total of 5 weeks, 4 weeks before performing the skin
incisions and 1 after the incisions were done. This study design
allowed us to better understand the potential health benefits of
regular ingestion of polyphenol-rich beverages in their natural
context and its potential preventive effect. Beer ingestion in our rat
experiment corresponded to a moderate alcohol intake by humans,
approximately to 0.9 L beer/day by a man of 60 kg [Reagan-Shaw
et al., 2008]. The establishment of the chronic treatment in our
experimental model gains particular relevance, considering that
polyphenols accumulate in macrophages and other cells or tissues at
relatively high concentrations [Kawai et al., 2008; Bolca et al.,
2010], when comparing with plasma concentrations. It has also been
suggested that polyphenols may exert biological effects through
specific targets at much lower concentrations than those initially
suspected. Indeed, low amounts of polyphenols may specifically
interact with proteins or particular lipid bilayer components
[Fraga et al., 2010] and this may also explain the observed
in vivo effects despite the low bioavailability described for
polyphenols.
In agreement with the literature, biochemical analyses of serum
parameters revealed no significant differences between the groups
treated with the different beverages, indicating a normal liver
function and lipid and carbohydrate metabolism in treated animals.
In line with our results, Dorn et al. [2010] described no adverse toxic
effects of 1,000mg XN /kg body weight/day after oral ingestion in
mice during 3 weeks. Other authors also observed no toxic effects
with 100mM ingestion of XN [Monteiro et al., 2008]. XN has been
described to alter lipid and carbohydrate metabolism, lowering
levels of plasma glucose and triglycerides [Gasowski et al., 2004;
Nozawa, 2005]. Although our results seemed to indicate a decrease
in serum triglycerides in SB and Suppl SB, these results were not
statistically different.
During the last decades, the beneficial role of polyphenols was
almost exclusively attributed to their anti-oxidant capacity, related
to the reduction of excessive production of reactive oxygen species,
which would induce an oxidative stress state [Holst and Williamson,
2008]. Nowadays, it is believed that polyphenol mechanisms of
action in vivo are much more complex and these compounds may
even exert their effect by acting as pro-oxidants, at low
concentrations, preparing cells to respond in more severe stress
conditions [Tosetti et al., 2009]. Ethanol by itself diminished GSSG
levels in serum but did not change GSH, resulting in a slight
increase, although not statistically significant, of the GSH/GSSG
ratio. Other authors suggest that moderate ethanol consumption can
stimulate anti-oxidative defences protecting from oxidation
produced by ethanol consumption. These authors reported an
increase in glutathione reductase activity, necessary for the
utilization of GSSG formed and regenerate the GSH, maintaining
the GSH/GSSG ratio, accordingly to our results [Assuncao et al.,
2009]. Other authors [Roig et al., 1999] observed similar effects in
what concern GSH/GSSH ratios for ethanol. Our results demon-
strated that XN, in the presence of ethanol, substantially and
significantly, increased GSH and diminished GSSG, resulting in a
great improvement of GSH/GSSG ratio, suggesting not only an
increase of anti-oxidant-defences but probably, a decrease in
oxidant levels due to its inherent anti-oxidant capacity. We found
that consumption of both SB and Suppl SB resulted in a significantly
higher GSH/GSSG ratio in serum than the one obtained in control
rats. Although not statistically significant the increase in GSH and
GSH/GSSG seems to be consistently higher for Suppl SB
comparatively with SB. Also, the difference of GSH between C or
Et groups and Suppl SB was statistically significant but not when
comparing C or Et with SB. In what concerns GSSG levels, both SB
and Suppl SB effects were similar.
GSH is used to eliminate peroxides, maintain thiol/disulfide redox
state of proteins, and maintain the redox state of ascorbate and
(indirectly) vitamin E in their reduced and functional forms [Jones,
2006]. The apparently higher level of GSH after Suppl SB ingestion
may be due to the higher levels of XN, a known anti-oxidant
polyphenol. This anti-oxidative capacity may be considered one of
the potential contributors to wound healing resolution by XN.
Altavilla et al. [2001] proposed that diabetes is associated with
elevated oxidative stress and inflammation, and that by reducing
Fig. 5. Adipocytes (A) size and (B) number observed under identity occulta-
tion in hematoxylin & eosin (HE)-stained 5mm-thick sections of skin wound
healing area. C, control (water-drinking animals); Et, 5% ethanol solution in
water; SB, Superbock1 stout beer; Suppl SB, xanthohumol-supplemented
Superbock1 stout beer. Results are represented as means SEM (4 n 6).
lipid peroxidation in wounds of diabetic mice, it would be possible
to reverse edema and stimulate the healing process. This would
correspond to the reversion of the negative effects of diabetes in
wound healing. In a recent paper [Strathmann et al., 2010], however,
XN is described as a rapid inducer of thiol depletion and a producer
of superoxide radical at mitochondria, inducing disruption of
mitochondrial integrity and apoptosis in cancer cells, but at much
higher concentrations (1.6–50mM) than those obtained in vivo, as
far as it has been described [Gerhauser, 2005].
Several studies have tried to evaluate the effect of ethanol
consumption on angiogenesis. Morrow et al. [2008] demonstrated
that moderate consumption of alcohol enhances endothelial pro-
angiogenic activity in vitro through a novel Notch-angiopoeitin-1/
Tie2 signaling pathway. Tan et al. [2007] reported that moderate
ethanol consumption (1% ethanol), associated with alcoholic
beverage consumption in humans, equivalent to two drinks per
day induced the expression of VEGF and angiogenesis in mice
melanoma. Other groups did also report an increase in angiogenesis
in different models both in vivo and in vitro [Gu et al., 2005; Bora
et al., 2006] in response to ethanol ingestion. On the other hand,
Radek et al. [2008] found that acute ethanol exposure impairs
angiogenesis probably by changes in the response to VEGF and
hypoxia by endothelial cells, in a wound healing model. Although
not statistically significant, our results suggest that chronic
ingestion of 5% ethanol increases the number of vessels formed
in the wound area, after 7 days of the injury, when compared to
control (water ingestion) as already described by other groups (see
above). Strikingly, SB and Suppl SB reversed ethanol effect.
Consistently, we observed an increase of systemic inflammatory
markers as well as VEGF upon consumption of ethanol, which was
again reversed by SB and Suppl SB.
In recent years the way we see adipose tissue has changed from a
simple lipid and energy storage to a multifunctional complex organ
with autocrine, paracrine, and endocrine functions. A remarkable
finding of the present work that corroborates this idea was the
appearance of distinct adipose tissue patterns within the granuloma
tissue upon different treatments. SB and particularly Suppl SB
consumption led to decreased adipocyte size and increased
adipocyte number in wounded skin corresponding to subcutaneous
adipose tissue. The precise function of these adipocytes in the
granulation tissue area remains unknown. Interestingly, adipocyte
hypertrophy has been associated with inflammatory dysfunction
[Monteiro et al., 2006; Monteiro, 2009]. It has been described that
adipose tissue from obese rats impaired wound contraction
associated with an increased inflammatory phase [Nascimento
and Costa, 2006]. Although necessary for wounds to heal,
inflammatory cytokines are present in excess in nonhealing
wounds. Adipocytes are known to communicate with endothelial
and inflammatory cells in a paracrine manner, through the
production of several cytokines that modulate blood vessel
remodeling and assembly, thus promoting the healing process.
Therefore, the fact that Suppl SB results in reduced adipocyte size
may imply a beneficial effect of this beverage on inflammation.
Furthermore, these results are in total agreement with the decreased
inflammatory markers and reduced redox state observed in the
serum of these rats. These findings suggest that XN is able to affect
adipose tissue homeostasis, increasing adipocyte hyperplasia and
reducing adipocyte hypertrophy, probably by affecting inflamma-
tory and vascular components. Nevertheless, definitely this
assumption deserves further investigation.
In summary, polyphenols are involved in complex signaling
networks between many cell types, including inflammatory,
endothelial, and adipocyte cells. The present study revealed that
chronic ingestion of SB and XN-supplemented stout beer are able to
control the complex interactions between inflammation and
angiogenic processes in skin wound healing, both locally and
systemically, resulting in improved wound healing resolution. These
effects suggest that this polyphenol may exert beneficial effect as a
nutritional supplement.
The interest in natural compounds, such as the polyphenols that
are useful for disease prevention or treatment is increasing.
Nevertheless, concern about potential toxic effects associated to
different doses, and individual metabolism, must be taken into
account before their implementation as food additives and potential
therapeutic agents.
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